Fortress Biotech Inc (NASDAQ:FBIO) Under Investigation for Investors Announced

An investigation on behalf of investors in Fortress Biotech Inc (NASDAQ:FBIO) shares over potential wrongdoing at Fortress Biotech Inc was announced and NASDAQ:FBIO stockholders should contact the Shareholders Foundation.

Logo

San Diego, CA -- (SBWire) -- 06/03/2016 --An investigation on behalf of current long-term investors in shares of Fortress Biotech Inc (NASDAQ:FBIO) was announced over potential breaches of fiduciary duties by certain directors at Fortress Biotech.

Investors who purchased shares of Fortress Biotech Inc (NASDAQ:FBIO) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.

The investigation by a law firm concerns whether certain Fortress Biotech Inc officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

Fortress Biotech Inc (NASDAQ:FBIO) reported that its Net Loss increased from $20.39 million in 2014 to $48.43 million in 2015. Shares of Fortress Biotech Inc (NASDAQ:FBIO) grew from $1.48 per share in August 2014 to $4.34 per share in April 2015.

On June 2, 2016, NASDAQ:FBIO shares closed at $2.89 per share.

Those who purchased shares of Fortress Biotech Inc have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

Media Relations Contact

Michael Daniels
General Manager
Shareholders Foundation
858-779-1554
http://www.ShareholdersFoundation.com

View this press release online at: http://rwire.com/695160